Understanding the Mechanism of the Broad-Spectrum Antiviral Activity of Favipiravir (T-705): Key Role of the F1 Motif of the Viral Polymerase

被引:52
作者
Abdelnabi, Rana [1 ]
de Morais, Ana Theresa Silveira [2 ]
Leyssen, Pieter [1 ]
Imbert, Isabelle [2 ]
Beaucourt, Stephanie [3 ]
Blanc, Herve [3 ]
Froeyen, Mathy [4 ]
Vignuzzi, Marco [3 ]
Canard, Bruno [2 ]
Neyts, Johan [1 ]
Delang, Leen [1 ]
机构
[1] KU Leuven Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium
[2] Aix Marseille Univ, UMR 7257, CNRS, Architecture & Fonct Macromol Biol, Marseille, France
[3] CNRS, Inst Pasteur, UMR 3569, Paris, France
[4] KU Leuven Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Rega Inst Med Res, Lab Med Chem, Leuven, Belgium
基金
欧盟第七框架计划;
关键词
favipiravir; fidelity; mutagenesis; RdRp; CVB3; DEPENDENT RNA-POLYMERASE; REPLICATION; ACTIVATION; RESISTANCE; MUTATIONS; INFECTION; RIBAVIRIN;
D O I
10.1128/JVI.00487-17
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Favipiravir (T-705) is a broad-spectrum antiviral agent that has been approved in Japan for the treatment of influenza virus infections. T-705 also inhibits the replication of various RNA viruses, including chikungunya virus (CHIKV). We demonstrated earlier that the K291R mutation in the F1 motif of the RNA-dependent RNA polymerase (RdRp) of CHIKV is responsible for low-level resistance to T-705. Interestingly, this lysine is highly conserved in the RdRp of positive-sense singlestranded RNA (+ ssRNA) viruses. To obtain insights into the unique broad-spectrum antiviral activity of T-705, we explored the role of this lysine using another +ssRNA virus, namely, coxsackievirus B3 (CVB3). Introduction of the corresponding K-to-R substitution in the CVB3 RdRp (K159R) resulted in a nonviable virus. Replication competence of the K159R variant was restored by spontaneous acquisition of an A239G substitution in the RdRp. A mutagenesis analysis at position K159 identified the K159M variant as the only other viable variant which had also acquired the A239G substitution. The K159 substitutions markedly decreased the processivity of the purified viral RdRp, which was restored by the introduction of the A239G mutation. The K159R A239G and K159M A239G variants proved, surprisingly, more susceptible than the wild-type virus to T-705 and exhibited lower fidelity in polymerase assays. Furthermore, the K159R A239G variant was found to be highly attenuated in mice. We thus demonstrate that the conserved lysine in the F1 motif of the RdRp of +ssRNA viruses is involved in the broad-spectrum antiviral activity of T-705 and that it is a key amino acid for the proper functioning of the enzyme. IMPORTANCE In this study, we report the key role of a highly conserved lysine residue of the viral polymerase in the broad-spectrum antiviral activity of favipiravir (T705) against positive-sense single-stranded RNA viruses. Substitutions of this conserved lysine have a major negative impact on the functionality of the RdRp. Furthermore, we show that this lysine is involved in the fidelity of the RdRp and that the RdRp fidelity influences the sensitivity of the virus for the antiviral efficacy of T-705. Consequently, these results provide insights into the mechanism of the antiviral activity of T-705 and may lay the basis for the design of novel chemical scaffolds that may be endowed with a more potent broad-spectrum antiviral activity than that of T-705.
引用
收藏
页数:15
相关论文
共 29 条
  • [1] Favipiravir elicits antiviral mutagenesis during virus replication in vivo
    Arias, Armando
    Thorne, Lucy
    Goodfellow, Ian
    [J]. ELIFE, 2014, 3 : e03679
  • [2] Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase
    Arnold, JJ
    Vignuzzi, M
    Stone, JK
    Andino, R
    Cameron, CE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (27) : 25706 - 25716
  • [3] Poliovirus RNA-dependent RNA polymerase (3Dpol) -: Assembly of stable, elongation-competent complexes by using a symmetrical primer-template substrate (sym/sub)
    Arnold, JJ
    Cameron, CE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) : 5329 - 5336
  • [4] T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
    Baranovich, Tatiana
    Wong, Sook-San
    Armstrong, Jianling
    Marjuki, Henju
    Webby, Richard J.
    Webster, Robert G.
    Govorkova, Elena A.
    [J]. JOURNAL OF VIROLOGY, 2013, 87 (07) : 3741 - 3751
  • [5] Mutations in the Nonstructural Protein 3A Confer Resistance to the Novel Enterovirus Replication Inhibitor TTP-8307
    De Palma, Armando M.
    Thibaut, Hendrik Jan
    van der Linden, Lonneke
    Lanke, Kjerstin
    Heggermont, Ward
    Ireland, Stephen
    Andrews, Robert
    Arimilli, Murty
    Al-Tel, Taleb H.
    De Clercq, Erik
    van Kuppeveld, Frank
    Neyts, Johan
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 1850 - 1857
  • [6] deAvila AI, 2016, PLOS ONE, V11
  • [7] Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral
    Delang, Leen
    Segura Guerrero, Nidya
    Tas, Ali
    Querat, Gilles
    Pastorino, Boris
    Froeyen, Mathy
    Dallmeier, Kai
    Jochmans, Dirk
    Herdewijn, Piet
    Bello, Felio
    Snijder, Eric J.
    de Lamballerie, Xavier
    Martina, Byron
    Neyts, Johan
    van Hemert, Martijn J.
    Leyssen, Pieter
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (10) : 2770 - 2784
  • [8] Structural insights into replication initiation and elongation processes by the FMDV RNA-dependent RNA polymerase
    Ferrer-Orta, Cristina
    Agudo, Ruben
    Domingo, Esteban
    Verdaguer, Nuria
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2009, 19 (06) : 752 - 758
  • [9] Mechanism of action of T-705 against influenza virus
    Furuta, Y
    Takahashi, K
    Kuno-Maekawa, M
    Sangawa, H
    Uehara, S
    Kozaki, K
    Nomura, N
    Egawa, H
    Shiraki, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 981 - 986
  • [10] Favipiravir (T-705), a novel viral RNA polymerase inhibitor
    Furuta, Yousuke
    Gowen, Brian B.
    Takahashi, Kazumi
    Shiraki, Kimiyasu
    Smee, Donald F.
    Barnard, Dale L.
    [J]. ANTIVIRAL RESEARCH, 2013, 100 (02) : 446 - 454